Establishment Labs Holdings Inc (NASDAQ: ESTA), a prominent name in the healthcare sector, specifically within the medical devices industry, has been drawing considerable attention from investors. Headquartered in the picturesque..
For investors with a keen eye on the healthcare sector, Surgery Partners, Inc. (NASDAQ: SGRY) presents an intriguing opportunity. With a market capitalization of $2.95 billion, this Brentwood, Tennessee-based company..
Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector’s medical care facilities industry, is capturing investor attention with its strong market potential and robust growth metrics...
Indivior PLC (INDV), a prominent player in the healthcare sector, is capturing investor attention with its compelling growth potential and an impressive 13.84% upside according to analyst ratings. Operating within..
For investors with an eye on the healthcare sector, Schrödinger, Inc. (NASDAQ: SDGR) presents a fascinating opportunity. Positioned within the Health Information Services industry, this New York-based company operates at..
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making noticeable waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.6 billion, Aurinia..
As the healthcare industry continues to embrace digital transformation, Teladoc Health, Inc. (NYSE: TDOC) stands at the forefront, offering innovative virtual healthcare services worldwide. However, with recent financial metrics posing..
Veracyte, Inc. (NASDAQ: VCYT), a leader in the diagnostics and research industry, is capturing investor attention with its robust product offerings and significant growth potential. Headquartered in South San Francisco,..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), headquartered in Hampton, New Jersey, stands out in the biotechnology industry with its innovative approach to tackling severe inflammatory, allergic, and autoimmune diseases. Specializing in..
Aveanna Healthcare Holdings Inc (AVAH) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a market cap of..
Integra LifeSciences Holdings C (NASDAQ: IART) is a notable player in the healthcare sector, specializing in the manufacture and distribution of medical devices. With a market capitalization of $1.11 billion,..
Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, is capturing attention with its promising pipeline in neuroscience therapeutics and a compelling 43.92% potential upside based on..
NeoGenomics, Inc. (NASDAQ: NEO), a leader in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a notable potential upside of 33.51%, according to recent analyst..
Biohaven Ltd. (NASDAQ: BHVN), a dynamic player in the healthcare sector specializing in biotechnology, is capturing investors’ attention with its impressive 215.55% potential upside. With a market cap of $1.58..
Viking Therapeutics, Inc. (NASDAQ: VKTX), a dynamic player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating metabolic and endocrine disorders. Headquartered in..
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a dynamic player in the biotechnology sector, has piqued investor interest with a 5.33% potential upside according to current analyst ratings. With a market capitalization..
For investors keeping a close eye on the biotechnology sector, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity with a notable potential upside of 22.59%. Headquartered in Newark, California,..
Mesoblast Limited (MESO), a prominent player in the biotechnology sector, is gaining attention from investors due to its significant potential upside. With a market capitalization of $2.03 billion, this Australian..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has garnered significant attention from investors, thanks to its robust revenue growth and promising analyst ratings. As a biopharmaceutical company, ANI Pharmaceuticals develops, manufactures, and..
